# Ugly Unicorn

Investor in Salt Lake City, Utah

## About Ugly Unicorn

Ugly Unicorn is a $20 million Blockchain-focused investment fund focused on providing our investors with risk mitigation strategies in the crypto and blockchain space.

We target risk-mitigated positions that provide an above-market risk-adjusted rate of return to investors.

Ugly Unicorn is a deep research team dedicated to finding “ugly unicorns” inside of the crypto, blockchain, and DeFi space. We leverage deep market research and technical market analysis to invest capital into high-yielding positions in these markets for the long term. This allows us to earn high yields while mitigating downside risk throughout market cycles.

Fund Strategy: We take a diversified approach to blockchain. We underwrite a potential investment based on three categories:

1) Experienced Team: Do they have a track record and something to lose if this doesn’t work?

2) Clear Roadmap and Compelling Future: What’s the growth potential of this technology, and what’s the path for its usage?

3) Real-World Utility: How many developers are building on the platform and using it every day?

## People

- **Bridger Pennington**, General Partner

## Key Facts

- **Location:** Salt Lake City, Utah
- **Investor Type:** Venture Capital
- **Founded:** 2022

## Investment Industry

- Cryptocurrency/Blockchain

## How to Contact

Direct messaging, this investor's website, and their LinkedIn profile are available with a paid Ask For Funding plan.

- [See plans and pricing](https://askforfunding.com/pricing)
- Already on a paid plan? [Log in](https://askforfunding.com/users/sign_in)

## More on Ask For Funding

- Full profile: https://askforfunding.com/investor/ugly-unicorn
- More investors: [Cryptocurrency Investors in Utah](https://askforfunding.com/site/angel-investors/utah/cryptocurrency)
- Find more investors: https://askforfunding.com/search/investors

Ask For Funding (AskForFunding.com) connects entrepreneurs with angel investors, private investors and venture capital firms in the United States, Canada and Australia.
